Published in Mol Cell Biol on August 16, 2010
Regulation of cell proliferation and migration by p62 through stabilization of Twist1. Proc Natl Acad Sci U S A (2014) 1.28
Epithelial-mesenchymal transition in cervical carcinoma. Am J Transl Res (2012) 1.15
KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells. Mol Cell Biol (2013) 0.94
UVB irradiation regulates ERK1/2- and p53-dependent thrombomodulin expression in human keratinocytes. PLoS One (2013) 0.80
TGF-β signaling links E-cadherin loss to suppression of nucleotide excision repair. Oncogene (2015) 0.77
Thrombomodulin promotes diabetic wound healing by regulating toll-like receptor 4 expression. J Invest Dermatol (2015) 0.76
Thrombomodulin expression regulates tumorigenesis in bladder cancer. BMC Cancer (2014) 0.76
EMT-Inducing Molecular Factors in Gynecological Cancers. Biomed Res Int (2015) 0.76
Myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss. Sci Rep (2016) 0.75
Thrombomodulin modulates cell migration in human melanoma cell lines. Melanoma Res (2014) 0.75
The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol (2000) 21.15
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer (2007) 18.69
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol (1988) 16.82
The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol (2000) 15.78
Epithelial-mesenchymal transitions: twist in development and metastasis. Cell (2004) 7.14
The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci (2003) 6.24
Snail blocks the cell cycle and confers resistance to cell death. Genes Dev (2004) 5.34
Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol (2003) 4.53
The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci U S A (2003) 4.41
Alpha-actinin revisited: a fresh look at an old player. Cell Motil Cytoskeleton (2004) 3.41
Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev (2003) 3.25
The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest (2002) 3.23
Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol (1991) 2.71
Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol (1998) 2.62
The regulation of natural anticoagulant pathways. Science (1987) 2.58
Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res (2004) 2.33
The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J Cell Biol (2005) 2.28
A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis. J Cell Biol (1991) 2.18
Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem (2005) 1.62
Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J (1987) 1.60
Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci U S A (1995) 1.58
Analysis of the E-cadherin repressor Snail in primary human cancers. Cells Tissues Organs (2007) 1.52
Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol (1994) 1.51
Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am J Pathol (2007) 1.41
Spectrin, alpha-actinin, and dystrophin. Adv Protein Chem (2005) 1.38
Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain. J Biol Chem (2003) 1.38
A training-testing approach to the molecular classification of resected non-small cell lung cancer. Clin Cancer Res (2003) 1.36
Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas. Clin Cancer Res (2008) 1.18
Snail-regulated genes in malignant melanoma. Melanoma Res (2005) 1.17
E-cadherin regulates the association between beta-catenin and actinin-4. Cancer Res (2005) 1.16
Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation. Biochem Biophys Res Commun (2007) 1.14
Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood (2008) 1.11
Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation. J Clin Invest (1994) 1.07
Regulation of epithelial wound closure and intercellular adhesion by interaction of AF6 with actin cytoskeleton. J Cell Sci (2006) 1.05
Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line. Br J Cancer (1995) 1.04
Effect of hepatocyte growth factor on cadherin-mediated cell-cell adhesion. Cell Struct Funct (1993) 1.04
Evidence of human thrombomodulin domain as a novel angiogenic factor. Circulation (2005) 1.01
Functional downregulation of the E-cadherin/catenin complex leads to loss of contact inhibition of motility and of mitochondrial activity, but not of growth in confluent epithelial cell cultures. Eur J Cell Biol (1997) 0.96
Functional and immunoreactive thrombomodulin expressed by keratinocytes. J Invest Dermatol (1994) 0.89
Expression of thrombomodulin in squamous cell carcinoma of the lung: its relationship to lymph node metastasis and prognosis of the patients. Cancer Lett (2000) 0.87
Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical study. Anticancer Res (1997) 0.85
Expression patterns of beta1-related alpha integrin subunits in murine lens during embryonic development and wound healing. Curr Eye Res (2004) 0.84
Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival. Br J Cancer (2006) 0.83
Thrombomodulin: tumour biology and prognostic implications. Eur J Surg Oncol (2005) 0.83
The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value. Clin Cancer Res (2004) 0.82
Silencing of the thrombomodulin gene in human malignant melanoma. Melanoma Res (2005) 0.81
Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea (2007) 1.68
Advanced penile verrucous carcinoma treated with intra-aortic infusion chemotherapy. J Urol (2010) 1.65
Angiogenin expression in burn blister fluid: implications for its role in burn wound neovascularization. Wound Repair Regen (2012) 1.60
Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb Haemost (2003) 1.53
The recombinant lectin-like domain of thrombomodulin inhibits angiogenesis through interaction with Lewis Y antigen. Blood (2011) 1.47
Thrombospondin-1 acts as a fence to inhibit angiogenesis that occurs during cervical carcinogenesis. Cancer J (2004) 1.46
WW domain-containing oxidoreductase: a candidate tumor suppressor. Trends Mol Med (2006) 1.44
Ofuji's disease with follicular mucinosis and its differential diagnosis from alopecia mucinosa. J Cutan Pathol (2003) 1.41
Phimosis with Preputial Fissures as a Predictor of Undiagnosed Type 2 Diabetes in Adults. Acta Derm Venereol (2016) 1.39
Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain. J Biol Chem (2003) 1.38
Deep partial thickness burn blister fluid promotes neovascularization in the early stage of burn wound healing. Wound Repair Regen (2010) 1.35
Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis. Hepatology (2009) 1.16
ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. Eur J Cancer (2010) 1.15
WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo. Clin Cancer Res (2005) 1.14
Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood (2008) 1.11
Antioxidant effects of black rice extract through the induction of superoxide dismutase and catalase activities. Lipids (2006) 1.07
A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways. Cancer Res (2011) 1.05
Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs. Circulation (2010) 1.05
Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction. Atherosclerosis (2006) 1.03
Evidence of human thrombomodulin domain as a novel angiogenic factor. Circulation (2005) 1.01
Patients with a large prostate show a higher prevalence of androgenetic alopecia. Arch Dermatol Res (2004) 1.00
The role of thrombomodulin lectin-like domain in inflammation. J Biomed Sci (2012) 1.00
Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis. Diabetologia (2013) 0.99
Antiangiogenic activity of Tripterygium wilfordii and its terpenoids. J Ethnopharmacol (2008) 0.99
Expression and function of proton-sensing G-protein-coupled receptors in inflammatory pain. Mol Pain (2009) 0.97
Squamous cell carcinoma of the big toe successfully treated by intra-arterial infusion with methotrexate. Dermatol Surg (2003) 0.97
Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus. Antimicrob Agents Chemother (2005) 0.96
Triptolide functions as a potent angiogenesis inhibitor. Int J Cancer (2010) 0.94
Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation. Cardiovasc Res (2011) 0.93
Prevalence of skin disease among nursing home patients in southern Taiwan. Int J Dermatol (2002) 0.93
Angiostatin antagonizes the action of VEGF-A in human endothelial cells via two distinct pathways. Biochem Biophys Res Commun (2003) 0.92
Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression. J Invest Dermatol (2008) 0.92
Increased aortic stiffness and attenuated lysyl oxidase activity in obesity. Arterioscler Thromb Vasc Biol (2013) 0.92
Salvianolic acid B modulates hemostasis properties of human umbilical vein endothelial cells. Thromb Res (2006) 0.91
Remodeling of carotid arteries is associated with increased expression of thrombomodulin in a mouse transverse aortic constriction model. Thromb Haemost (2007) 0.90
The angiogenesis inhibitor protease-activated kringles 1-5 reduces the severity of murine collagen-induced arthritis. Arthritis Res Ther (2002) 0.90
Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome. Am J Cardiol (2006) 0.90
Functions of rhomboid family protease RHBDL2 and thrombomodulin in wound healing. J Invest Dermatol (2011) 0.90
Stromal cell-derived factor-1/CXC receptor 4 and β1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells. J Cell Physiol (2012) 0.89
TXAS-deleted mice exhibit normal thrombopoiesis, defective hemostasis, and resistance to arachidonate-induced death. Blood (2004) 0.89
Thrombomodulin is an ezrin-interacting protein that controls epithelial morphology and promotes collective cell migration. FASEB J (2012) 0.89
Ets-1 mediates platelet-derived growth factor-BB-induced thrombomodulin expression in human vascular smooth muscle cells. Cardiovasc Res (2008) 0.89
Vesicular pemphigoid with circulating autoantibodies against 230-kDa and 180-kDa proteins, and additional autoantibodies against 97-kDa and 45-kDa proteins. Int J Dermatol (2007) 0.88
Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice. Cardiovasc Res (2009) 0.88
S100A2, a potential marker for early recurrence in early-stage oral cancer. Oral Oncol (2005) 0.88
The epidermal growth factor-like domain of CD93 is a potent angiogenic factor. PLoS One (2012) 0.88
Geldanamycin interferes with the 90-kDa heat shock protein, affecting lipopolysaccharide-mediated interleukin-1 expression and apoptosis within macrophages. Mol Pharmacol (2006) 0.88
2-methoxyestradiol induces mitotic arrest, apoptosis, and synergistic cytotoxicity with arsenic trioxide in human urothelial carcinoma cells. PLoS One (2013) 0.88
Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction. Thromb Haemost (2002) 0.87
Lysophosphatidic acid stimulates thrombomodulin lectin-like domain shedding in human endothelial cells. Biochem Biophys Res Commun (2007) 0.87
Traffic-related air pollution, climate, and prevalence of eczema in Taiwanese school children. J Invest Dermatol (2008) 0.87
Nestin serves as a prosurvival determinant that is linked to the cytoprotective effect of epidermal growth factor in rat vascular smooth muscle cells. J Biochem (2009) 0.87
The cleavage plane of corneal epithelial adhesion complex in traumatic recurrent corneal erosion. Mol Vis (2006) 0.86
Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma. Mol Cancer Res (2006) 0.86
Benzyl butyl phthalate induces migration, invasion, and angiogenesis of Huh7 hepatocellular carcinoma cells through nongenomic AhR/G-protein signaling. BMC Cancer (2014) 0.86
Hexavalent chromium induced ROS formation, Akt, NF-kappaB, and MAPK activation, and TNF-alpha and IL-1alpha production in keratinocytes. Toxicol Lett (2010) 0.86
A color-based approach for automated segmentation in tumor tissue classification. Conf Proc IEEE Eng Med Biol Soc (2007) 0.86
Thrombomodulin plays an important role in arterial remodeling and neointima formation in mouse carotid ligation model. Thromb Haemost (2006) 0.86
FIX-Triple, a gain-of-function factor IX variant, improves haemostasis in mouse models without increased risk of thrombosis. Thromb Haemost (2010) 0.86
Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol (2003) 0.86
Gene targeting and expression analysis of mouse Tem1/endosialin using a lacZ reporter. Gene Expr Patterns (2011) 0.86
Anti-angiogenesis mediated by angiostatin K1-3, K1-4 and K1-4.5. Involvement of p53, FasL, AKT and mRNA deregulation. Thromb Haemost (2006) 0.85
A novel inhibitory effect of naloxone on macrophage activation and atherosclerosis formation in mice. J Am Coll Cardiol (2006) 0.85
Prognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary intervention. Eur Heart J (2003) 0.85
Using a co-culture microsystem for cell migration under fluid shear stress. Lab Chip (2011) 0.85
Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor. Arterioscler Thromb Vasc Biol (2009) 0.85
Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. J Immunol (2011) 0.84
STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production. Angiogenesis (2012) 0.84
A novel role of thrombospondin-1 in cervical carcinogenesis: inhibit stroma reaction by inhibiting activated fibroblasts from invading cancer. Carcinogenesis (2008) 0.84